Latest updates for Biosneds Apigensol

Fresh curated links around BioSNEDS ApigenSol are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • Apogee Therapeutics: Targeting Atopic Dermatitis
  • Precigen (PGEN) Secures FDA Orphan Drug Exclusivity for PAPZIMEOS
  • Ingredion acquires Benicaros that supports immune health at low daily dosage

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

seekingalpha.com /1 month ago

Apogee Therapeutics: Targeting Atopic Dermatitis

Read source
finance.yahoo.com /3 weeks ago

Precigen (PGEN) Secures FDA Orphan Drug Exclusivity for PAPZIMEOS

Read source
fnbnews.com /1 month ago

Ingredion acquires Benicaros that supports immune health at low daily dosage

Ingredion Incorporated NYSE INGR a leading global provider of ingredient solutions for the food beverage and industrial markets announced the acquisition of Benicaros a patented pr...

Read source
fiercebiotech.com /3 weeks ago

Sanofi, Pangaea ink AI partnership deal to detect underdiagnosed genetic disease

French biopharma Sanofi inked a partnership deal with Pangaea Data to use its AI platform that helps detect Alpha-1 Antitrypsin Deficiency (AATD) that will be distributed to select...

Read source
genengnews.com /3 weeks ago

AbbVie to Acquire Apogee Therapeutics for $10.9B

Apogee’s lead candidate zumilokibart, an IL-13 inhibitor also called APG777, is a long-acting treatment that, according to the company, holds “pipeline-in-a-product potential” beca...

Read source
genengnews.com /2 weeks ago

Peptistar Began Operation of the Asahi Kasei FO-MD System at Manufacturing Scale

FO utilizes an osmotic pressure difference across a membrane to remove water from liquids, achieving highly concentrated API solutions under mild conditions. MD leverages a vapor p...

Read source
genengnews.com /1 month ago

Skape Bio Unlocks Generalizable GPCR Drugs Using AI Protein Design

David Baker’s latest company is making medicines for a huge protein family once deemed undruggable. A new study generated miniproteins that target GPCRs across a diversity of recep...

Read source
prweb.com /2 weeks ago

Major Biopharmaceutical Company Files First-in-Human Trial Supported by PAK BioSolutions GMP Purification System

A major biopharmaceutical company has filed a First-in-Human (FIH) clinical trial application with drug product manufactured using the PAK BioSolutions system. The milestone demons...

Read source
biopharmadive.com /2 days ago

Agenus surges on study pivot; Apnimed lines up an IPO

Agenus is financially abandoning an ongoing study in late-line colorectal cancer. Elsewhere, an ebola vaccine began human testing and an important Bristol Myers medicine got an FDA...

Read source
food-safety.com /2 weeks ago

NOW, LeafWorks Advance Identity Verification Testing for Botanical Ingredients

The platform was developed to address limitations of earlier DNA barcoding methods by using species-targeted genomic approaches, authenticated reference materials, and analytical s...

Read source
pharmexec.com /1 week ago

<![CDATA[The Only AI Simulation Built for Life Sciences ]]>

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Biosneds Apigensol

food-safety.com

Recent coverage from public sources
Public source

seekingalpha.com

Recent coverage from public sources
Public source

fnbnews.com

Recent coverage from public sources
Public source

feeds.feedburner.com

Recent coverage from public sources
Public source

finance.yahoo.com

Recent coverage from public sources
Public source

biopharmadive.com

Recent coverage from public sources
Public source